Intraoperative Imaging, Navigation, and Pituitary Surgery Outcomes: Intraoperative Imaging Modalities in Pituitary Surgery.
Authors
Affiliations (3)
Affiliations (3)
- Department of Neurosurgery, MedStar Georgetown University Hospital, Washington, D.C., USA; Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA.
- Department of Radiology, Mayo Clinic, Rochester, MN, USA.
- Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA; Department of Otorhinolaryngology and Head and Neck Surgery, Mayo Clinic, Rochester, MN, USA. Electronic address: [email protected].
Abstract
This article reviews the evolution, current applications, and emerging technologies of intraoperative imaging and navigation in pituitary neuroendocrine tumor surgery. Established modalities include frameless stereotactic navigation, intraoperative computed tomography, intraoperative MRI, intraoperative ultrasound, and fluorescence-guided surgery, each offering distinct advantages in tumor localization, extent-of-resection assessment, anatomic orientation, and complication avoidance. Intraoperative MRI provides the most robust soft-tissue visualization but is limited by cost and workflow complexity, while ultrasound and fluorescence offer more accessible real-time adjuncts. Emerging technologies such as optical coherence tomography, Raman spectroscopy, intraoperative PET, augmented reality, and artificial intelligence may further improve tumor discrimination and surgical decision-making.